Illumina’s Acquisition of PacBio: Accelerating the Pace of Genomic Discovery

DNA sequencing and DNA strand
Source: KTSDesign/Science Photo Library/Getty Images

Illumina just purchased Pacific BioSciences (PacBio) for $1.2 billion. Shawn Baker formerly worked for Illumina as both a scientist and manager. He currently serves as the chief science officer for AllSeq and as a genomics startup advisor and consultant at GEN asked Shawn about the significance of Illumina buying PacBio to the sequencing market and to obtain his take on what’s driving the Illumina deal?

This site uses Akismet to reduce spam. Learn how your comment data is processed.